secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001193125-26-152868
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology sells $25M in stock to Mayo Clinic with option for additional $25M
--------------------------------------------------------------------------------

- Issued 7,507,507 shares at $3.33 each to Mayo Clinic for ~$25M gross proceeds; closing expected April 15, 2026.
- Mayo Clinic can purchase another 7,507,507 shares at same price by Aug 31, 2026, for ~$25M additional.
- Net proceeds to fund development of SC451 and genetically modified stem-cell derived islet cell products under new license agreement.
- Mayo Clinic subject to 6-month lock-up from initial closing (or 3 months from second closing if elected).
- Cash of $138.4M (Dec 31, 2025) plus ~$24.9M net from initial closing expected to fund operations into 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526152868/0001193125-26-152868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526152868/sana-20260410.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-152868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer